The model demonstrated promising predictive ability for early-onset hypoglycemia in preterm infants and could potentially serve as a preliminary tool to inform risk stratification strategies. However, its clinical translation requires confirmation through external validation in prospective, multicenter studies before any consideration of widespread implementation.
Li et al. (Thu,) studied this question.